Loading chart…
CLOSED
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Consumer Products, and Medical Technologies. The company offers active pharmaceutical ingredients, human and finished dosage formulations, generics, branded generics, specialty formulations, biosimilars, vaccines, novel therapeutics, medical devices and technologies, consumer wellness, veterinary, and animal health products.
Zydus Lifesciences Limited (ZYDUSLIFE) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ZYDUSLIFE share price is ₹1,199.50 (+0.54% today), with a market capitalisation of ₹1.20T and a price-to-earnings (P/E) ratio of 28.7. MarketRipple tracks the ZYDUSLIFE investment thesis, the ripple-chain impact of market events on Zydus Lifesciences Limited, and the Healthcare sector outlook.
Open
₹1,200.00
High
₹1,209.80
Low
₹1,187.60
Prev. Close
₹1,193.00
52W High
₹1,266.60
52W Low
₹835.50
Day range
₹1,187.60–₹1,209.80
52-week range
₹835.50–₹1,266.60
Volume
276K
P/E
28.7
ROE
14.7%
D/E
0.46
Margin
13.8%
Zydus Lifesciences Limited (NSE: ZYDUSLIFE) is currently trading at ₹1,199.50 (+0.54%).
Zydus Lifesciences Limited's market capitalization is ₹1.20T.
Zydus Lifesciences Limited's price-to-earnings (P/E) ratio is 28.7.
Zydus Lifesciences Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Zydus Lifesciences Limited currently reads neutral, based on 29 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.